U.S. Markets closed

Cyren Ltd: Cyren Announces Third Quarter 2019 Financial Results

Year-to-date revenue up 9% despite slight revenue decline during quarter

MCLEAN, VA / ACCESSWIRE / November 13, 2019 / Cyren (CYRN) today announced its third quarter 2019 financial results for the period ending September 30, 2019.

During the third quarter, Cyren reported quarterly revenues of $9.5 million, compared to $9.6 million during the third quarter of 2018. For the first three quarters of 2019, year-to-date revenues were $28.9 million, which represents a 9% annual increase over the first three quarters of 2018.

GAAP net loss for the quarter was $3.5 million, compared to $4.4 million during the third quarter of 2018. Year-to-date, net loss declined to $12.7 million compared to a net loss of $13.8 million over the same period a year ago.

"Our top priority is driving more aggressive growth and we are refining our strategy to take advantage of the market opportunities we see," said Brett Jackson, CEO of Cyren. "Our team has made very good progress over the past several months and are now very focused on execution. We expect to begin seeing the benefits from our key initiatives emerging over the next several quarters."

Third Quarter 2019 Financial Highlights:

  • Revenues for the third quarter of 2019 were $9.5 million, compared to $9.6 million during the third quarter of 2018.
  • GAAP net loss for the third quarter of 2019 was $3.5 million, compared to a net loss of $4.4 million in the third quarter of 2018.
  • GAAP loss per basic and diluted share for the third quarter of 2019 was $0.06, compared to a loss of $0.08 per basic and diluted share for the third quarter of 2018.
  • Non-GAAP net loss for the third quarter of 2019 was $3.5 million, compared to a Non-GAAP net loss of $3.3 million for the third quarter of 2018.
  • Non-GAAP loss per basic and diluted share was $0.06 for the third quarter of 2019, compared to a Non-GAAP loss of $0.06 per share in third quarter of 2018.
  • Cash used in operating activities during the third quarter of 2019 was $1.7 million, compared to operating cash usage of $2.6 million during the third quarter of 2018.
  • Net cash flow for the third quarter of 2019 was negative $2.9 million, compared to negative $3.1 million during the third quarter of 2018.
  • Cash balance as of September 30, 2019, was $9.5 million, compared to $17.6 million as of December 31, 2018. This does not include the proceeds of the Rights Offering detailed below.

For information regarding the non-GAAP financial measures discussed in this release, please see "Use of Non-GAAP Financial Measures" and "Reconciliation of Selected GAAP Measures to Non-GAAP Measures."

Rights Offering:

During the third quarter, Cyren announced a Rights Offering to shareholders of record as of September 25. Right holders were entitled to purchase one ordinary share at a subscription price of $1.73 per share. The Rights Offering closed on November 6, 2019 and generated approximately $8 million of gross proceeds to Cyren, which is not reflected in the September 30, 2019 cash balance. Pursuant to the Rights Offering, Cyren issued a total of 4,635,584 ordinary shares at $1.73 per share, including 4,624,277 shares issued to the company's majority shareholder, WP XII Investments B.V., an entity controlled by funds affiliated with Warburg Pincus. After the offering, Cyren now has 59,319,391 shares outstanding.

Financial Results Conference Call:

The company will host a conference call at 10 a.m. Eastern Time (5 p.m. Israel Time) on Wednesday, November 13, 2019 to discuss third quarter results.

U.S. Dial-in Number: 1-877-407-0312
Israel Dial-in Number: 1-80-940-6247
International Dial-in Number: 1-201-389-0899

The call will be simultaneously webcast live on the investor relations section of Cyren's website at https://ir.cyren.com, or by using the following link: https://webcasts.eqs.com/cyren20191113/.

For those unable to participate in the live conference call, a replay will be available until November 27, 2019. To access the replay, the U.S. dial in number is 1-877-660-6853 and the non-U.S. dial in number is 1-201-612-7415. Callers will be prompted for replay conference ID number 13696074. An archived version of the webcast will also be available on the investor relations section of the company's website at https://ir.cyren.com/events.

About Cyren:

More than 1.3 billion users around the world rely on Cyren's 100% cloud security solutions to protect them against cyber attacks and data loss every day. Powered by the world's largest security cloud, Cyren (CYRN) delivers fast time-to-protection with award-winning email security, cloud sandboxing and DNS filtering services for business, and threat intelligence solutions for service providers and security vendors like Microsoft, Google and Check Point. Learn more at www.cyren.com.

Blog: http://blog.cyren.com
Facebook: www.facebook.com/CyrenWeb
LinkedIn: www.linkedin.com/company/cyren
Twitter: www.twitter.com/CyrenInc

Use of Non-GAAP Financial Measures:

Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: stock-based compensation expenses, amortization of acquired intangible assets, and deferred taxes related to acquisitions, adjustments to earn-out obligations, and capitalization of technology. The purpose of such adjustments is to give an indication of the company's performance exclusive of non-cash charges and other items that are considered by management to be outside of the company's core operating results. The company's non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read only in conjunction with the company's consolidated financial statements prepared in accordance with GAAP.

Company management regularly uses supplemental non-GAAP financial measures internally to understand, manage and evaluate the business and make operating decisions.

These non-GAAP measures are among the primary factors management uses in planning for and forecasting future periods. The company believes this adjustment is useful to investors as a measure of the ongoing performance of the business. The company believes these non-GAAP financial measures provide consistent and comparable measures to help investors understand the company's current and future operating cash flow performance. These non-GAAP financial measures may differ materially from the non-GAAP financial measures used by other companies. Reconciliation between results on a GAAP and non-GAAP basis is provided in a table immediately following the Consolidated Statements of Income. The presentation of this non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Management uses both GAAP and non-GAAP measures when evaluating the business internally and therefore felt it important to make these non-GAAP adjustments available to investors.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. For example, statements in the future tense, and statements including words such as "expect," "plan," "estimate," "anticipate," or "believe" are forward-looking statements. These statements are based on information available at the time of the press release and the company assumes no obligation to update any of them. The statements in this press release are not guarantees of future performance and actual results could differ materially from current expectations as a result of numerous factors, including our CEO transition, business conditions and growth or deterioration in the internet security market, technological developments, products offered by competitors, availability of qualified staff, and technological difficulties and resource constraints encountered in developing new products, as well as those risks described in the company's publicly filed reports, which are available through www.sec.gov.

CYREN LTD.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands of U.S. dollars, except per share amounts)

Three months ended Nine months ended
September 30 September 30
2019 2018 2019 2018
Unaudited Unaudited Unaudited Unaudited
Revenues
$ 9,496 $ 9,562 $ 28,862 $ 26,388
Cost of revenues
3,712 3,670 11,501 10,684
Gross profit
5,784 5,892 17,361 15,704
Operating expenses:
Research and development, net
3,516 4,336 11,990 11,355
Sales and marketing
3,027 3,931 10,473 12,133
General and administrative
2,484 2,166 7,314 6,151
Total operating expenses
9,027 10,433 29,777 29,639
Operating loss
(3,243 ) (4,541 ) (12,416 ) (13,935 )
Other income (expense), net
(3 ) - 262 (17 )
Financial income (expense), net
(321 ) 7 (642 ) (91 )
Loss before taxes
(3,567 ) (4,534 ) (12,796 ) (14,043 )
Tax benefit
37 107 117 201
Net loss
$ (3,530) $ (4,427) $ (12,679) $ (13,842)
Loss per share - basic and diluted
$ (0.06 ) $ (0.08 ) $ (0.23 ) $ (0.26 )
Weighted average number of shares outstanding:
Basic and Diluted
54,554 53,679 54,389 53,503

CYREN LTD.
RECONCILIATION OF SELECTED GAAP MEASURES TO NON-GAAP MEASURES
(in thousands of U.S.dollars, except per share amounts)

Three months ended Nine months ended
September 30 September 30
2019 2018 2019 2018
Unaudited Unaudited Unaudited Unaudited
GAAP gross profit
$ 5,784 $ 5,892 $ 17,361 $ 15,704
GAAP gross margin
61 % 62 % 60 % 60 %
Plus:
Stock-based compensation
36 48 98 124
Amortization of intangible assets
758 907 2,364 2,692
Non-GAAP gross profit
6,578 6,847 19,823 18,520
Non-GAAP gross margin
69 % 72 % 69 % 70 %
GAAP operating loss
(3,243 ) (4,541 ) (12,416 ) (13,935 )
Plus:
Stock-based compensation
419 358 1,002 1,031
Amortization of intangible assets
883 1,060 2,736 3,157
Capitalization of technology
(1,118 ) (242 ) (2,510 ) (1,886 )
Non-GAAP operating loss
(3,059 ) (3,365 ) (11,188 ) (11,633 )
GAAP net loss
(3,530 ) (4,427 ) (12,679 ) (13,842 )
Plus:
Stock-based compensation expense
419 358 1,002 1,031
Intangible amortization expense
883 1,060 2,736 3,157
Adjustment to earn-out liabilities
- 23 - 75
Amortization of deferred tax assets
(55 ) (62 ) (170 ) (188 )
Gain from an earn-out liability settlement
- - (256 ) -
Capitalization of technology
(1,169 ) (242 ) (2,627 ) (1,886 )
Non-GAAP net loss
$ (3,452 ) $ (3,290 ) $ (11,994 ) $ (11,653 )
Numerator for non-GAAP EPS calculation
$ (3,452 ) $ (3,290 ) $ (11,994 ) $ (11,653 )
Non-GAAP net loss per share
$ (0.06 ) $ (0.06 ) $ (0.22 ) $ (0.22 )
GAAP weighted-average shares used to
compute net loss per share
54,554 53,679 54,389 53,503

CYREN LTD.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands of U.S. dollars)

September 30 December 31
2019 2018
Unaudited Audited
Assets
Current Assets:
Cash and cash equivalents
$ 9,546 $ 17,571
Trade receivables, net
3,499 3,658
Deferred commissions
930 887
Prepaid expenses and other receivables
1,329 778
Total current assets
15,304 22,894
Long-term deferred commissions
1,646 1,880
Long-term lease deposits
782 821
Operating lease right-of-use assets
8,974 -
Severance pay fund
610 503
Property and equipment, net
4,437 4,608
Intangible assets, net
8,667 8,802
Goodwill
19,904 20,519
Total long-term assets
45,020 37,133
Total assets
$ 60,324 $ 60,027
Liabilities and Shareholders' Equity
Current Liabilities:
Trade payables
$ 1,402 $ 1,668
Employees and payroll accruals
3,690 3,959
Accrued expenses and other liabilities
1,421 910
Operating lease liabilities
1,298 -
Earn-out consideration
- 2,926
Deferred revenues
9,270 5,773
Total current liabilities
17,081 15,236
Deferred revenues
2,944 503
Convertible notes
10,000 10,000
Long-term operating lease liabilities
7,993 -
Deferred tax liability
912 1,130
Accrued severance pay
778 598
Other liabilities
337 700
Total long-term liabilities
22,964 12,931
Shareholders' equity
20,279 31,860
Total liabilities and shareholders' equity
$ 60,324 $ 60,027

CYREN LTD.
CONDENSED CONSOLIDATED CASH FLOW DATA
(in thousands of U.S. dollars)

Three months ended Nine months ended
September 30 September 30
2019 2018 2019 2018
Cash flows from operating activities:
Unaudited Unaudited Unaudited Unaudited
Net loss
$ (3,530 ) $ (4,427 ) $ (12,679 ) $ (13,842 )
Loss on disposal of property and equipment
- - 1 14
Depreciation
484 438 1,420 1,434
Stock-based compensation
419 358 1,002 1,031
Amortization of intangible assets
885 1,060 2,736 3,157
Amortization of deferred commissions
(297 ) 445 (909 ) 1,005
Amortization of operating lease right-of-use assets
338 - 1,051 -
Interest on convertible notes
142 - 424 -
Other expenses (income) related to the earn-out consideration
- 23 (257 ) 75
Deferred taxes, net
(55 ) (57 ) (182 ) (152 )
Changes in assets and liabilities:
Trade receivables
(509 ) (607 ) 196 (292 )
Prepaid expenses and other receivables
168 306 (607 ) (392 )
Deferred commissions
353 (954 ) 1,101 (1,797 )
Change in long-term lease deposits
2 5 25 (110 )
Trade payables
559 375 (264 ) 306
Employees and payroll accruals, accrued expenses and other liabilities
39 346 (185 ) 677
Deferred revenues
(357 ) 110 5,997 3,040
Accrued severance pay, net
5 21 73 (120 )
Operating lease liabilities
(342 ) - (1,075 ) -
Other long-term liabilities
(15 ) 1 (126 ) 71
Net cash provided by (used in) operating activities
(1,711 ) (2,557 ) (2,258 ) (5,895 )
Cash flows from investing activities:
Proceeds from sale of property and equipment
1 - 1 -
Capitalization of technology, net of grants received
(1,027 ) (384 ) (2,462 ) (1,844 )
Purchase of property and equipment
(309 ) (1,156 ) (1,259 ) (2,989 )
Net cash used in investing activities
(1,335 ) (1,540 ) (3,720 ) (4,833 )
Cash flows from financing activities:
Payment of earnout liability
- - (2,680 ) (604 )
Proceeds from options exercised
231 984 743 1,276
Net cash provided by (used in) financing activities
231 984 (1,937 ) 672
Effect of exchange rate changes on cash
(76 ) 12 (124 ) (39 )
Increase (decrease) in cash, cash equivalents and restricted cash
(2,891) (3,101) (8,039) (10,095)
Cash, cash equivalents and restricted cash at the beginning of the period
13,008 17,234 18,156 24,228
Cash, cash equivalents and restricted cash at the end of the period
$ 10,117 $ 14,133 $ 10,117 $ 14,133
Reconciliation of cash, cash equivalents and restricted cash as shown in the consolidated statements of cash flow:
Cash and cash equivalents
$ 9,546 $ 13,527 $ 9,546 $ 13,527
Restricted cash included in long-term restricted lease deposits
571 606 571 606
Total cash, cash equivalents and restricted cash
$ 10,117 $ 14,133 $ 10,117 $ 14,133


Company Contact
Mike Myshrall, CFO
Cyren

+1.703.760.3320
mike.myshrall@cyren.com

SOURCE: Cyren Ltd



View source version on accesswire.com:
https://www.accesswire.com/566311/Cyren-Ltd-Cyren-Announces-Third-Quarter-2019-Financial-Results